213 related articles for article (PubMed ID: 24577891)
1. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies.
Zhou J; Liu T; Wang W
Medicine (Baltimore); 2018 Nov; 97(44):e13051. PubMed ID: 30383677
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta-analysis.
Liu Y; Wang Y; Teng Z; Chen J; Li Y; Chen Z; Li Z; Zhang Z
Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26239566
[TBL] [Abstract][Full Text] [Related]
4. Comments on Li H et al. "A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma".
Zhang Q; Li J; Liu F; Li Z
Tumour Biol; 2015 Jan; 36(1):5-6. PubMed ID: 25416443
[TBL] [Abstract][Full Text] [Related]
5. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.
Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T
Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
Chen D; Zhang YJ; Zhu KW; Wang WC
Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
Wen X; Liu H; Yu K; Liu Y
Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
[TBL] [Abstract][Full Text] [Related]
8. Association of MMP-2 expression and prognosis in osteosarcoma patients.
Zhang M; Zhang X
Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.
Fu Y; Lan T; Cai H; Lu A; Yu W
Medicine (Baltimore); 2018 May; 97(19):e0741. PubMed ID: 29742740
[TBL] [Abstract][Full Text] [Related]
10. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Han J; Yong B; Luo C; Tan P; Peng T; Shen J
World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.
Jiao G; Ren T; Lu Q; Sun Y; Lou Z; Peng X; Liang W; Guo W
Tumour Biol; 2013 Oct; 34(5):2489-95. PubMed ID: 23857285
[TBL] [Abstract][Full Text] [Related]
12. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
Chen J; Sun MX; Hua YQ; Cai ZD
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
[TBL] [Abstract][Full Text] [Related]
14. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.
Futamura N; Nishida Y; Urakawa H; Kozawa E; Ikuta K; Hamada S; Ishiguro N
Tumour Biol; 2014 Jun; 35(6):5159-65. PubMed ID: 24481662
[TBL] [Abstract][Full Text] [Related]
15. The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis.
Zhang C; Wang L; Xiong C; Zhao R; Liang H; Luo X
J Orthop Surg Res; 2021 Dec; 16(1):738. PubMed ID: 34963495
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 9 (MMP-9) in osteosarcoma: review and meta-analysis.
Wang J; Shi Q; Yuan TX; Song QL; Zhang Y; Wei Q; Zhou L; Luo J; Zuo G; Tang M; He TC; Weng Y
Clin Chim Acta; 2014 Jun; 433():225-31. PubMed ID: 24704305
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
Huang JF; Du WX; Chen JJ
J BUON; 2016; 21(5):1279-1286. PubMed ID: 27837634
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of elevated ezrin in patients with osteosarcoma.
Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]